Discover 3,488 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study]
for
Rheumatoid Arthritis (RA)
Location: Covina CA, Temecula CA, Glendale AZ, Aurora CO,
Sponsor: SecondWave Systems Inc.
Sex: All
Age: 18+
Code: NCT07163221
Recruiting
FeaturedActive & Responsive
Evaluating tDCS Brain-stimulation in Depression Using MRI
for
Major Depressive Disorder
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 20 - 55
Code: NCT05598034
Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Santa Ana CA, Los Angeles CA, Santa Monica CA,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase2, Recruiting
Active & Responsive
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
for
Diabetic Macular Edema
Location: Santa Ana CA, Fullerton CA, Bakersfield CA, Oakland CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT04108156
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
for
Depressive Disorder, Major
Location: Santa Ana CA, Orange CA, Bellflower CA, Redlands CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 64
Code: NCT06785012
Phase2, Recruiting
Active & Responsive
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
for
Hemophilia B
Location: Orange CA, Memphis TN, Atlanta GA, Ann Arbor MI,
Sponsor: CSL Behring
Sex: Male
Age: 11 - 17
Code: NCT07080905
Phase3, Recruiting
Active & Responsive
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
for
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Location: Orange CA, Redwood City CA, Seattle WA, Kansas City MO,
Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Sex: All
Age: 0 - 70+
Code: NCT05500807
Phase1, Recruiting
Active & Responsive
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease